Document Detail

Successful autologous bone marrow rescue in patients who failed peripheral blood stem cell mobilization.
MedLine Citation:
PMID:  11195005     Owner:  NLM     Status:  MEDLINE    
We assessed autologous bone marrow (BM) harvest and hematologic recovery after high-dose chemotherapy (HDCT) in patients who failed to achieve peripheral blood stem cell (PBSC) mobilization. One hundred and ninety-three patients with germ cell tumor, malignant lymphoma, sarcoma or medulloblastoma were scheduled for HDCT. In 123 patients, PBSC were mobilized by disease-specific chemotherapy plus granulocyte colony-stimulating factor (G-CSF). In 110/ 123 patients (89%) with circulating CD34+ cell counts 2 > or = 10/microl, sufficient hematopoietic autografts were collected (group A). In 13/123 patients (11%) with peripheral CD34 + cell counts < 10/microl, PBSC harvesting was not performed (group B). These latter patients were classified as "poor mobilizers" and underwent second-line BM harvest at a median of 46 (range 10-99) days after mobilization failure. Seventy patients with first-line BM harvest (group C) acted as historical controls. Ten patients from group B proceeded to HDCT and nine were evaluable for hematopoietic reconstitution. Recovery to neutrophils >0.5 x 10(9)/l was comparable with group C patients: 16 (range 9-34) days vs 13 (range 8-98) days. However, platelet (PLT) reconstitution >20 x 10(9)/l was significantly slower, with a median of 35 (range 13-50) days as compared with 19 (range 9-148) days (P = 0.0106) for control patients. Supportive care requirements, febrile days and length of hospital stay were not significantly different between the two groups of patients. We conclude that patients who fail to mobilize PBSC should be evaluated for second-line BM harvest. This approach may preserve the therapeutic option of HDCT for these patients.
O Rick; J Beyer; D Kingreen; J S Kühl; J Zingsem; D Huhn; W Siegert; N Schwella
Related Documents :
3678475 - Correlation between bone marrow karyotype and the occurrence of erythroblast micronucle...
21163125 - Clinical and prognostic characteristics of 573 cases of primary sjögren's syndrome.
2052705 - Vertebral density distribution pattern: ct classification of patients undergoing mainte...
3415365 - Spinal trabecular bone mineral content in patients with non-steroid treated rheumatoid ...
19343165 - Takayasu arteritis presenting as postpartum cardiomyopathy.
10683215 - Noncompliance with fda and society guidelines for endoscopic reprocessing: implications...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Annals of hematology     Volume:  79     ISSN:  0939-5555     ISO Abbreviation:  Ann. Hematol.     Publication Date:  2000 Dec 
Date Detail:
Created Date:  2001-01-18     Completed Date:  2001-01-25     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9107334     Medline TA:  Ann Hematol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  681-6     Citation Subset:  IM    
Klinik für Innere Medizin mS Hämatologie/Onkologie, Charité, Humboldt-Universität, Berlin, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antineoplastic Agents / administration & dosage
Bone Marrow Transplantation*
Dose-Response Relationship, Drug
Hematologic Neoplasms / therapy
Hematopoietic Stem Cell Mobilization*
Hematopoietic Stem Cell Transplantation*
Middle Aged
Retrospective Studies
Tissue and Organ Harvesting
Treatment Outcome
Reg. No./Substance:
0/Antineoplastic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Immunoelectron microscopic analysis of CD 54 surface distribution and its role in homotypic interact...
Next Document:  Plasma kinetics of an artificial emulsion resembling chylomicrons in patients with chronic lymphocyt...